Sound View Wealth Advisors Group, LLC Gilead Sciences, Inc. Transaction History
Sound View Wealth Advisors Group, LLC
- $933 Million
- Q1 2024
A detailed history of Sound View Wealth Advisors Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sound View Wealth Advisors Group, LLC holds 9,026 shares of GILD stock, worth $609,706. This represents 0.07% of its overall portfolio holdings.
Number of Shares
9,026
Previous 9,435
4.33%
Holding current value
$609,706
Previous $764,000
13.48%
% of portfolio
0.07%
Previous 0.08%
Shares
16 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.28 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.75 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.71 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.14 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.9 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $84.7B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...